Physiological and pathological actions of sphingosine 1-phosphate

Seminars in Cell and Developmental Biology

Volumn 15, Issue 5, 2004, Pages 513-520

  Hla, Timothy ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Angiogenesis; Immunity; Limb development; Lipid mediators; Sphingosine 1 phosphate

Indexed keywords

FINGOLIMOD; G PROTEIN COUPLED RECEPTOR; LIPID; SPHINGOMYELIN; SPHINGOSINE 1 PHOSPHATE;

ANGIOGENESIS; AUTOIMMUNITY; BLOOD VESSEL PERMEABILITY; BLOOD VESSEL TONE; CANCER; CARBOHYDRATE METABOLISM; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; FEMALE INFERTILITY; GENITAL SYSTEM; GRAFT REJECTION; HEART FUNCTION; HEART INFARCTION; HUMAN; IMMUNOCOMPETENT CELL; LIMB DEVELOPMENT; MEDIATOR; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PROTEIN EXPRESSION; REVIEW; SKELETON;

MAMMALIA;

EID: 3242696730     PISSN: 10849521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcdb.2004.05.002     Document Type: Article

References (69)

1. Hannun Y.A., Luberto C., Argraves K.M. Enzymes of sphingolipid metabolism: from modular to integrative signaling. Biochemistry. 40:2001;4893-4903
2. Hla T., Lee M.J., Ancellin N., Paik J.H., Kluk M.J. Lysophospholipids - receptor revelations. Science. 294:2001;1875-1878
3. Postma F.R., Jalink K., Hengeveld T., Moolenaar W.H. Sphingosine-1- phosphate rapidly induces Rho-dependent neurite retraction: action through a specific cell surface receptor. EMBO J. 15:1996;2388-2392
4. Igarashi Y. Functional roles of sphingosine, sphingosine 1-phosphate, and methylsphingosines: in regard to membrane sphingolipid signaling pathways. J. Biochem. (Tokyo). 122:1997;1080-1087
5. Lee M.J., Van Brocklyn J.R., Thangada S., Liu C.H., Hand A.R., Menzeleev R., et al. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science. 279:1998;1552-1555
6. Pyne S. Cellular signaling by sphingosine and sphingosine 1-phosphate. Their opposing roles in apoptosis. Subcell. Biochem. 36:2002;245-268
7. Spiegel S., Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat. Rev. Mol. Cell Biol. 4:2003;397-407
8. Goetzl E.J. Pleiotypic mechanisms of cellular responses to biologically active lysophospholipids. Prostaglandins. 64:2001;11-20
9. Chun J., Goetzl E.J., Hla T., Igarashi Y., Lynch K.R., Moolenaar W., et al. International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature. Pharmacol. Rev. 54:2002;265-269
10. Nichols F.C. Novel ceramides recovered from Porphyromonas gingivalis: relationship to adult periodontitis. J. Lipid Res. 39:1998;2360-2372
11. Hla T. Signaling and biological actions of sphingosine 1-phosphate. Pharmacol. Res. 47:2003;401-407
12. Yatomi Y., Ozaki Y., Ohmori T., Igarashi Y. Sphingosine 1-phosphate: synthesis and release. Prostaglandins. 64:2001;107-122
13. Hla T., Maciag T. An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled receptors. J. Biol. Chem. 265:1990;9308-9313
14. Lee M.J., Thangada S., Claffey K.P., Ancellin N., Liu C.H., Kluk M., et al. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell. 99:1999;301-312
15. Morales-Ruiz M., Lee M.J., Zollner S., Gratton J.P., Scotland R., Shiojima I., et al. Sphingosine 1-phosphate activates Akt, nitric oxide production, and chemotaxis through a Gi protein/phosphoinositide 3-kinase pathway in endothelial cells. J. Biol. Chem. 276:2001;19672-19677
16. Igarashi J., Bernier S.G., Michel T. Sphingosine 1-phosphate and activation of endothelial nitric-oxide synthase. differential regulation of Akt and MAP kinase pathways by EDG and bradykinin receptors in vascular endothelial cells. J. Biol. Chem. 276:2001;12420-12426
17. Dantas A.P., Igarashi J., Michel T. Sphingosine 1-phosphate and control of vascular tone. Am. J. Physiol. Heart Circ. Physiol. 284:2003;H2045-2052
18. Tosaka M., Okajima F., Hashiba Y., Saito N., Nagano T., Watanabe T., et al. Sphingosine 1-phosphate contracts canine basilar arteries in vitro and in vivo: possible role in pathogenesis of cerebral vasospasm. Stroke. 32:2001;2913-2919
19. Ohmori T., Yatomi Y., Osada M., Kazama F., Takafuta T., Ikeda H., et al. Sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via S1P2. Cardiovasc. Res. 58:2003;170-177
20. Coussin F., Scott R.H., Wise A., Nixon G.F. Comparison of sphingosine 1-phosphate-induced intracellular signaling pathways in vascular smooth muscles: differential role in vasoconstriction. Circ. Res. 91:2002;151-157
21. Liu Y., Wada R., Yamashita T., Mi Y., Deng C.X., Hobson J.P., et al. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J. Clin. Invest. 106:2000;951-961
22. Allende M.L., Yamashita T., Proia R.L. G-protein-coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation. Blood. 102:2003;3665-3667
23. Mohle R., Green D., Moore M.A., Nachman R.L., Rafii S. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc. Natl. Acad. Sci. U.S.A. 94:1997;663-668
24. Paik J.H., Chae S., Lee M.J., Thangada S., Hla T. Sphingosine 1-phosphate-induced endothelial cell migration requires the expression of EDG-1 and EDG-3 receptors and Rho-dependent activation of alpha vbeta3- and beta1-containing integrins. J. Biol. Chem. 276:2001;11830-11837
25. Lee M.J., Thangada S., Paik J.H., Sapkota G.P., Ancellin N., Chae S.S., et al. Akt-mediated phosphorylation of the G protein-coupled receptor EDG-1 is required for endothelial cell chemotaxis. Mol. Cell. 8:2001;693-704
26. Senger D.R., Van de Water L., Brown L.F., Nagy J.A., Yeo K.T., Yeo T.K., et al. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev. 12:1993;303-324
27. Dvorak H.F., Detmar M., Claffey K.P., Nagy J.A., van de Water L., Senger D.R. Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation. Int. Arch. Allergy Immunol. 107:1995;233-235
28. Sanchez T., Estrada-Hernandez T., Paik J.H., Wu M.T., Venkataraman K., Brinkmann V., et al. Phosphorylation and action of the immunomodulator FTY720 inhibits VEGF-induced vascular permeability. J. Biol. Chem. 278(47):2003;47281- 47290
29. Graeler M., Goetzl E.J. Activation-regulated expression and chemotactic function of sphingosine 1-phosphate receptors in mouse splenic T cells. FASEB J. 16:2002;1874-1878
30. Graler M.H., Goetzl E.J. Lysophospholipids and their G protein-coupled receptors in inflammation and immunity. Biochim. Biophys. Acta. 1582:2002;168-174
31. Brinkmann V., Lynch K.R. FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity. Curr. Opin. Immunol. 14:2002;569-575
32. Brinkmann V., Davis M.D., Heise C.E., Albert R., Cottens S., Hof R., et al. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J. Biol. Chem. 277:2002;21453-21457
33. Mandala S., Hajdu R., Bergstrom J., Quackenbush E., Xie J., Milligan J., et al. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science. 296:2002;346-349
34. Allende M.L., Dreier J.L., Mandala S., Proia R.L. Expression of the sphingosine-1-phosphate receptor S1P1 on T cells controls thymic emigration. J. Biol. Chem. 279:2004;15396-15401
35. Matloubian M., Lo C.G., Cinamon G., Lesneski M.J., Xu Y., Brinkmann V., et al. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature. 427:2004;355-360
36. Sanna M.G., Liao J., Jo E., Alfonso C., Ahn M.Y., Peterson M.S., et al. Distinct S1P receptor subtypes S1P1 and S1P3 respectively regulate lymphocyte recirculation and heart rate. J. Biol. Chem. 279:2004;13839-13848
37. Forrest M., Sun S.Y., Hajdu R., Bergstrom J., Card D., Hale J., et al. Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor sub-types. J. Pharmacol. Exp. Ther. 309:2004;758-768
38. Graler M.H., Goetzl E.J. The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G protein-coupled receptors. FASEB J. 18:2004;551-553
39. Buxser S., Decker D., Ruppel P. Relationship among types of nerve growth factor receptors on PC12 cells. J Biol. Chem. 265:1990;12701-12710
40. Baxter J.D., Funder J.W. Hormone receptors. N. Engl. J. Med. 301:1979;1149-1161
41. Chae S.S., Proia R.L., Hla T. Constitutive expression of the S1P1 receptor in adult tissues. Prostaglandins Other Lipid Mediat. 73:2004;141-150
42. Liu C.H., Hla T. The mouse gene for the inducible G-protein-coupled receptor edg-1. Genomics. 43:1997;15-24
43. Zhang G., Contos J.J., Weiner J.A., Fukushima N., Chun J. Comparative analysis of three murine G-protein coupled receptors activated by sphingosine-1-phosphate. Gene. 227:1999;89-99
44. Ishii I., Friedman B., Ye X., Kawamura S., McGiffert C., Contos J.J., et al. Selective loss of sphingosine 1-phosphate signaling with no obvious phenotypic abnormality in mice lacking its G protein-coupled receptor, LP(B3)/EDG-3. J. Biol. Chem. 276:2001;33697-33704
45. Ishii I., Ye X., Friedman B., Kawamura S., Contos J.J., Kingsbury M.A., et al. Marked perinatal lethality and cellular signaling deficits in mice null for the two sphingosine 1-phosphate (S1P) receptors, S1P(2)/LP(B2)/EDG-5 and S1P(3)/LP(B3)/EDG-3. J. Biol. Chem. 277:2002;25152-25159
46. Van Brocklyn J.R., Tu Z., Edsall L.C., Schmidt R.R., Spiegel S. Sphingosine 1-phosphate-induced cell rounding and neurite retraction are mediated by the G protein-coupled receptor H218. J. Biol. Chem. 274:1999;4626-4632
47. Windh R.T., Lee M.J., Hla T., An S., Barr A.J., Manning D.R. Differential coupling of the sphingosine 1-phosphate receptors Edg-1, Edg-3, and H218/Edg-5 to the G(i), G(q), and G(12) families of heterotrimeric G proteins. J. Biol. Chem. 274:1999;27351-27358
48. McGiffert C., Contos J.J., Friedman B., Chun J. Embryonic brain expression analysis of lysophospholipid receptor genes suggests roles for s1p(1) in neurogenesis and s1p(1-3) in angiogenesis. FEBS Lett. 531:2002;103-108
49. Weiner J.A., Fukushima N., Contos J.J., Scherer S.S., Chun J. Regulation of Schwann cell morphology and adhesion by receptor-mediated lysophosphatidic acid signaling. J. Neurosci. 21:2001;7069-7078
50. Chae S.S., Paik J.H., Allende M.L., Proia R.L., Hla T. Regulation of limb development by the sphingosine 1-phosphate receptor S1p1/EDG-1 occurs via the hypoxia/VEGF axis. Dev. Biol. 268:2004;441-447
51. Grey A, Xu X, Hill B, Watson M, Callon K, Reid IR, et al. Osteoblastic cells express phospholipid receptors and phosphatases and proliferate in response to sphingosine-1-phosphate. Calcif Tissue Int 2004.
52. Suomalainen L., Hakala J.K., Pentikainen V., Otala M., Erkkila K., Pentikainen M.O., et al. Sphingosine-1-phosphate in inhibition of male germ cell apoptosis in the human testis. J. Clin. Endocrinol. Metab. 88:2003;5572-5579
53. Otala M., Suomalainen L., Pentikainen M.O., Kovanen P., Tenhunen M., Erkkila K., et al. Protection from radiation-induced male germ cell loss by sphingosine-1-phosphate. Biol. Reprod. 70:2004;759-767
54. Yatomi Y., Welch R.J., Igarashi Y. Distribution of sphingosine 1-phosphate, a bioactive sphingolipid, in rat tissues. FEBS Lett. 404:1997;173-174
55. Tilly J.L., Kolesnick R.N. Sphingolipids, apoptosis, cancer treatments and the ovary: investigating a crime against female fertility. Biochim. Biophys. Acta. 1585:2002;135-138
56. Kolesnick R., Fuks Z. Radiation and ceramide-induced apoptosis. Oncogene. 22:2003;5897-5906
57. Spiegel S., Milstien S. Sphingosine 1-phosphate, a key cell signaling molecule. J Biol Chem. 277:2002;25851-25854
58. Xia P., Gamble J.R., Wang L., Pitson S.M., Moretti P.A., Wattenberg B.W., et al. An oncogenic role of sphingosine kinase. Curr. Biol. 10:2000;1527-1530
59. French K.J., Schrecengost R.S., Lee B.D., Zhuang Y., Smith S.N., Eberly J.L., et al. Discovery and evaluation of inhibitors of human sphingosine kinase. Cancer Res. 63:2003;5962-5969
60. Takuwa Y. [Regulation of Rho family G proteins and cell motility by the Edg family of sphingosin 1-phosphate receptors]. Tanpakushitsu Kakusan Koso. 47:2002;496-502
61. Arikawa K., Takuwa N., Yamaguchi H., Sugimoto N., Kitayama J., Nagawa H., et al. Ligand-dependent inhibition of B16 melanoma cell migration and invasion via endogenous S1P2 G protein-coupled receptor. Requirement of inhibition of cellular RAC activity. J. Biol. Chem. 278:2003;32841-32851
62. Yamaguchi H., Kitayama J., Takuwa N., Arikawa K., Inoki I., Takehara K., et al. Sphingosine-1-phosphate receptor subtype-specific positive and negative regulation of Rac and haematogenous metastasis of melanoma cells. Biochem. J. 374:2003;715-722
63. Kluk M.J., Hla T. Role of the sphingosine 1-phosphate receptor EDG-1 in vascular smooth muscle cell proliferation and migration. Circ. Res. 89:2001;496-502
64. Xia P., Gamble J.R., Rye K.A., Wang L., Hii C.S., Cockerill P., et al. Tumor necrosis factor-alpha induces adhesion molecule expression through the sphingosine kinase pathway. Proc. Natl. Acad. Sci. U.S.A. 95:1998;14196-14201
65. Yang Z., Chen M., Fialkow L.B., Ellett J.D., Wu R., Brinkmann V., et al. The immune modulator FYT720 prevents autoimmune diabetes in nonobese diabetic mice small star, filled. Clin. Immunol. 107:2003;30-35
66. Kitabayashi H., Isobe M., Watanabe N., Suzuki J., Yazaki Y., Sekiguchi M. FTY720 prevents development of experimental autoimmune myocarditis through reduction of circulating lymphocytes. J. Cardiovasc. Pharmacol. 35:2000;410-416
67. Kurose S., Ikeda E., Tokiwa M., Hikita N., Mochizuki M. Effects of FTY720, a novel immunosuppressant, on experimental autoimmune uveoretinitis in rats. Exp. Eye Res. 70:2000;7-15
68. Hozumi Y., Kobayashi E., Miyata M., Fujimura A. Immunotherapy for experimental rat autoimmune thyroiditis using a novel immunosuppressant, FTY720. Life Sci. 65:1999;1739-1745
69. Okazaki H., Hirata D., Kamimura T., Sato H., Iwamoto M., Yoshio T., et al. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus. J. Rheumatol. 29:2002;707-716